Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jolande Boes"'
Autor:
Fons G. C. M. Uytdehaag, R.S. van Binnendijk, Jolande Boes, C. A. van Baalen, A.D.M.E. Osterhaus, P de Vries, Martien C. M. Poelen, Vincenzo Cerundolo
Publikováno v:
Scopus-Elsevier
The Journal of Experimental Medicine
The Journal of Experimental Medicine
The routes used by antigen-presenting cells (APC) to convert the transmembrane fusion glycoprotein (F) of measles virus (MV) to HLA class I and class II presentable peptides have been examined, using cloned cytotoxic T lymphocytes in functional assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e447ccee8adef6557f71064127645f
https://doi.org/10.1084/jem.176.1.119
https://doi.org/10.1084/jem.176.1.119
Autor:
Esther C. de Jong, Paul J.M. Roholl, Mariska E. A. van Dijk, Grada M. van Bleek, Toni M.M. van Capel, Patricia M. A. de Graaff, Jolande Boes, Jan L. L. Kimpen, Willem Luytjes
Publikováno v:
Journal of immunology (Baltimore, Md., 175(9), 5904-5911. American Association of Immunologists
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in children, the elderly, and immune-compromised individuals. CD4 and CD8 T cells play a crucial role in the elimination of RSV from the infected lung, bu
Autor:
Jolande Boes, Teun Guichelaar, Widjojoatmodjo Myra Noorely, Sylvia S. N. Reemers, Rob Otten, Cécile A. C. M. van Els, Willem Luytjes, Jeroen Hoeboer, Yvonne van Remmerden
Elderly humans are prone to severe infection with human respiratory syncytial virus (HRSV). The aging of today's human population warrants the development of protective vaccination strategies aimed specifically at the elderly. This may require specia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302b3990b5d0f3150d741ea46453a0f0
https://europepmc.org/articles/PMC4136321/
https://europepmc.org/articles/PMC4136321/
Autor:
Gideon F.A. Kersten, Germie P. J. M. van den Dobbelsteen, Petra de Vries, Kristian Dalsgaard, Arjen Spiekstra, Paul G.H. Mulder, Paul J.M. Roholl, Loek van Alphen, Jolande Boes, Albert D. M. E. Osterhaus, Koert J. Stittelaar
Publikováno v:
Vaccine, 18, 2482-2493. Elsevier
Semipurified Quil A and purified Quil A were used to prepare well-characterized subunit vaccine candidates against measles. Variation in the relative amounts of the measles virus (MV) fusion (F) protein, Quil A-components and lipids did not influence
Autor:
Yvonne van Remmerden, Rik L. de Swart, D. Tien Nguyen, Albert D. M. E. Osterhaus, Jolande Boes, Teun Guichelaar, Selma Yüksel, Geert van Amerongen
Publikováno v:
Human Vaccines & Immunotherapeutics, 9(12), 2578-2583. Landes Bioscience
Development of live-attenuated human respiratory syncytial virus (HRSV) vaccines has proven to be difficult. Several vaccine candidates were found to be over-attenuated and displayed limited immunogenicity. Recently, we identified three synthetic cat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f883a3bd9bf9e79bed40052a0159d4
https://pure.eur.nl/en/publications/9e5638fd-0550-4ea8-8aeb-3048fa60acbf
https://pure.eur.nl/en/publications/9e5638fd-0550-4ea8-8aeb-3048fa60acbf
Autor:
Marnix L. Bosch, Jolande Boes, Jonathan L. Heeney, Petra de Vries, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Ellen G.J. Hulskotte, Stephen Norley
Publikováno v:
Vaccine. 13:1187-1197
Shortly after infection of two rhesus monkeys (Macaca mulatta) either with a SIVmac32H challenge stock or with the same virus that had been passaged in another rhesus monkey for 11 months, SIV-envelope genes were cloned from their peripheral blood mo
Autor:
Marleen van Bers, Willem Luytjes, Paul J.M. Roholl, Yvonne van Remmerden, Jolande Boes, Widjojoatmodjo Myra Noorely
Publikováno v:
Virology Journal, Vol 7, Iss 1, p 114 (2010)
Virology Journal
Virology Journal
Background Respiratory syncytial virus (RSV) is a primary cause of serious lower respiratory tract illness for which there is still no safe and effective vaccine available. Using reverse genetics, recombinant (r)RSV and an rRSV lacking the G gene (Δ
Autor:
Henk Niphuis, Jolande Boes, Albert D. M. E. Osterhaus, Willem Koornstra, Marlinda E. M. Dings, Rob Dubbes, Jonathan L. Heeney, Bror Morein, Peter ten Haaft, Petra de Vries
Publikováno v:
Journal of Medical Primatology. 21:126-130
This study attempted to determine if SIV vaccines could protect against challenge with peripheral blood mononuclear cells (PBMCs) from an SIV infected rhesus monkey. Mature Macaca mulatta were vaccinated four times with formalin inactivated SIVmac32H
Autor:
John Nieland, Claire J. P. Boog, C. J. M. Melief, Jolande Boes, Jacques Neefjes, M. L. H. De Bruijn, Hidde L. Ploegh
Publikováno v:
The Journal of Experimental Medicine
The B6 anti-bm6 allospecific CTL response is strictly dependent on CD4+ cells when using LPS blasts as stimulator cells. Altering the N-linked carbohydrates on stimulator cells by use of the N-linked trimming glycosidase inhibitors 1-deoxymannojirimy
Autor:
Ellen G.J. Hulskotte, Lennart Åkerblom, Marlinda E. M. Dings, Jolande Boes, Sigrid Eriksson, Bror Morein, Peter ten Haaft, Rob Dubbes, S. Norley, Albert D. M. E. Osterhaus, Jonathan L. Heeney, Petra de Vries, Willem Koornstra
Publikováno v:
Vaccine. 12(15)
The immunogenicity and efficacy of an inactivated whole SIVmac (32H) preparation adjuvanted with muramyl dipeptide (SIV-MDP) and a gp120-enriched SIVmac (32H) ISCOM preparation (SIV-ISCOM), were compared by immunizing four rhesus macaques (Macaca mul